Overexpression of phospho mutant forms of transglutaminase 2 downregulates epidermal growth factor receptor

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 251-255

  Wang, Yi ^a   Ande, Sudharsana R ^a   Mishra, Suresh ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Embryonic fibroblasts; Mutagenesis; Phosphorylation; Protein kinase A; Protein kinase B

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; ATTENUATION; CANCER CELL; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GTP-BINDING PROTEINS; MICE; MICE, MUTANT STRAINS; MUTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSGLUTAMINASES;

MUS;

EID: 84855757434     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.094     Document Type: Article

References (21)

1. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 2002, 27:534-539.
2. Li B., Antonyak M.A., Druso J.E., Cheng L., Nikitin A.Y., Cerione R.A. EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proc. Natl. Acad. Sci. USA 2010, 107:1408-1413.
3. Ohtake Y., Kobayashi T., Maruko A., et al. Norepinephrine modulates zonally different hepatocyte proliferation through the regulation of transglutaminase activity. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G106-G114.
4. Li Z., Xu X., Bai L., et al. Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J. Biol. Chem. 2011, 286:21264-21272.
5. Zhang R., Tremblay T.L., McDermid A., Thibault P., Stanimirovic D. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia 2003, 42:194-208.
6. Hansen L.A., Alexander N., Hogan M.E., Sundberg J.P., Dlugosz A., Threadgill D.W., Magnuson T., Yuspa S.H. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am. J. Pathol. 1997, 150:1959-1975.
7. Cheng X., Jin J., Hu L., et al. TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation. Cell 2010, 141:331-343.
8. Antonyak M.A., Miller A.M., Jansen J.M., et al. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J. Biol. Chem. 2004, 279:41461-41467.
9. Kim D.S., Park S.S., Nam B.H., Kim I.H., Kim S.Y. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res. 2006, 66:10936-10943.
10. Yuan L., Siegel M., Choi K., et al. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 2007, 26:2563-2573.
11. Verma A., Guha S., Wang H., et al. Tissue transglutaminase regulates focal adhesion kinase/Akt activation by modulating PTEN expression in pancreatic cancer cells. Clin. Cancer Res. 2008, 4:1997-2004.
12. Maehama T., Dixon J.E. The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol3, 4, 5-trisphosphate. J. Biol. Chem. 1998, 273:13375-13378.
13. Stambolic V., Suzuki A., de la Pompa J.L. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
14. Y. Wang, S.R. Ande, S. Mishra, Phosphorylation of transglutaminase 2 (TG2) at serine-216 plays a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN, Unpublished results.
15. Rikova K., Guo A., Zeng Q., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
16. Guo A., Villén J., Kornhauser J., et al. Signaling networks assembled by oncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. USA 2008, 105:692-697.
17. Mishra S., Murphy L.J. Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites. Bichem. Biophy. Res. Commun. 2006, 347:1166-1170.
18. Mishra S., Melino G., Murphy L.J. Transglutaminase 2 kinase activity facilitates protein kinase A induced phosphorylation of retinoblastoma protein. J. Biol. Chem. 2007, 282:18108-18115.
19. Salazar G., González A. Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition. Mol. Biol. Cell. 2002, 13:1677-1693.
20. Sarbassov D., Guertin D., Ali S., Sabatini D. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
21. Wu Y.-T., Ouyang W., Lazorchak A.S., et al. J. Biol. Chem. 2011, 286:14190-14198.